Amarin (AMRN -0.9%) says the European Patent Office has issued an intention to grant letter for...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN -0.9%) says the European Patent Office has issued an intention to grant letter for a patent application the company filed to protect the exclusivity of it's drug candidate, AMR101. The patent covers the drugs use in treating Hypertriglyceridemia, an indication that AMRN may seek through the European Medicines Agency. An FDA decision on the drug is due out tomorrow.